IBL HEALTHCARE LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 32.25 PKR | +3.56% |
|
+3.46% | -10.96% |
| 04-29 | IBL HealthCare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024 | CI |
| 04-26 | IBL Healthcare Limited Announces CEO Changes | CI |
| Sales 2022 | 3.65B 13.13M 1.05B | Sales 2023 | 4.03B 14.48M 1.15B | Capitalization | 2.32B 8.36M 666M |
|---|---|---|---|---|---|
| Net income 2022 | 303M 1.09M 86.8M | Net income 2023 | 309M 1.11M 88.52M | EV / Sales 2022 | 0.97 x |
| Net Debt 2022 | 163M 586K 46.71M | Net Debt 2023 | 202M 726K 57.81M | EV / Sales 2023 | 0.63 x |
| P/E ratio 2022 |
11.1
x | P/E ratio 2023 |
7.52
x | Employees | 311 |
| Yield 2022 |
1.92% | Yield 2023 |
-
| Free-Float | 23.74% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +3.56% | ||
| 1 week | +3.46% | ||
| Current month | +3.33% | ||
| 1 month | -1.53% | ||
| 3 months | +0.06% | ||
| 6 months | -2.71% | ||
| Current year | -10.96% |
1 week
30.50
32.74
1 month
30.5033.50
Current year
29.0037.10
1 year
24.2943.50
3 years
24.2982.54
5 years
13.9582.54
10 years
13.95104.99
| Managers | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | - | - | |
| Director/Board Member | - | - | |
Hussain Murtaza
SEC | Corporate Secretary | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | - | |
| Director/Board Member | 60 | - | |
Munis Abdullah
BRD | Director/Board Member | - | 23/02/21 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/05/24 | 32.7 | +1.40% | 254,000 |
| 06/05/24 | 32.25 | +3.56% | 226,500 |
| 03/05/24 | 31.14 | +0.45% | 36,000 |
| 02/05/24 | 31 | -0.67% | 76,500 |
| 30/04/24 | 31.21 | +0.13% | 13,000 |
End-of-day quote Pakistan S.E., May 05, 2024
More quotes
IBL HealthCare Limited is engaged in marketing, selling and distribution of healthcare products. The Company's product categories include nutrition, health, and wellness, ophthalmic, medical disposables, and pharmaceutical. The nutrition category includes toddlers, baby cereals, medical nutrition, lifestyle nutrition, specialty, and infant formulas. The health and wellness category includes consumer health, and hygiene and safety. The ophthalmic category includes vision care and pharma. The Medical Disposables category consists of renal care, critical care and anesthesia, non-drug, blood transfusion, IV administration, and medical gloves. The Pharmaceutical category consists of various products, such as Seapride, Luxave, Conifa, M-Floxin, Urisolin, Hyplar, Ezcolic, Clariza, and Eprazin. The Company is a subsidiary of The Searle Company Limited and International Brands Limited.
Sector
Drug Retailers
| 1st Jan change | Capi. | |
|---|---|---|
| -10.96% | 9.93M | |
| -33.32% | 14.89B | |
| -25.06% | 12.2B | |
| -28.07% | 6.54B | |
| +13.49% | 6.37B | |
| -9.19% | 6.03B | |
| -0.44% | 4.73B | |
| +59.80% | 4.57B | |
| -9.15% | 3.82B | |
| -10.56% | 3.51B |
- Stock Market
- Equities
- IBLHL Stock
